Immunoguided lymph node dissection in colorectal cancer: A new challenge?

Keyphrases

• Colorectal Cancer 100%
• Tumor Site 100%
• Lymph Node Dissection 100%
• Monoclonal Antibody 66%
• Tumor 66%
• Lymph Node 66%
• Positive Predictive Value 66%
• Negative Predictive Value 66%
• Hematoxylin-eosin Staining 66%
• Decision-making Process 33%
• Major Change 33%
• Glycoprotein 33%
• Lymphoid Tissue 33%
• Tumor-associated 33%
• Patient with Tumor 33%
• Surgeons 33%
• Lymphatics 33%
• Decision Basis 33%
• Informed Decision-making 33%
• Patients with Colorectal Cancer 33%
• Lymphatic Tissue 33%
• Surgical Planning 33%
• Surgical Exploration 33%
• Detecting Probe 33%
• CC49 33%
• Non-lymphoid Tissues 33%
• Recurrent Colorectal Cancer 33%
• Occult Tumor 33%
• TAG-72 33%
• Postoperative Therapy 33%
• Iodine-125 33%
• Lymphatic Involvement 33%

Medicine and Dentistry

• Neoplasm 100%
• Colorectal Carcinoma 100%
• Retroperitoneal Lymph Node Dissection 100%
• Lymphatic Tissue 50%
• Lymph Duct 33%
• Lymph Node 33%
• Haematoxylin 33%
• Eosin 33%
• Decision Making 16%
• Monoclonal Antibody 16%
• Surgeon 16%
• Postoperative Care 16%
• Iodine 125 16%
• Surgical Exploration 16%
• Monoclonal Antibody CC49 16%
• Tumor-Associated Glycoprotein 72 16%

Immunology and Microbiology

• Lymph Node 100%
• Lymphoid Tissue 66%
• Monoclonal Antibody 33%
• Decision Making 33%
• Glycoprotein 33%
• Iodine-125 33%
• Monoclonal Antibody CC49 33%